A Cell Type Selective YM155 Prodrug Targets Receptor-Interacting Protein Kinase 2 to Induce Brain Cancer Cell Death
Por um escritor misterioso
Descrição
Frontiers Overcoming Resistance to Natural Killer Cell Based
Paul S. Mischel's research works
Cancer multidrug-resistance reversal by ABCB1 inhibition: A recent
Molecules, Free Full-Text
The solute carrier SLC35F2 enables YM155-mediated DNA damage
Parenteral high‑dose ascorbate - A possible approach for the
Cells, Free Full-Text
The solute carrier SLC35F2 enables YM155-mediated DNA damage
Mitochondrial DNA-targeted therapy: A novel approach to combat
Frontiers Publishing Partnerships
Mitochondrial DNA-targeted therapy: A novel approach to combat
Targeted therapy for non‐small‐cell lung cancer: New insights into
Enzymatically Forming Intranuclear Peptide Assemblies for
Cells, Free Full-Text
de
por adulto (o preço varia de acordo com o tamanho do grupo)